Dr Stefanie Dolen, DO | |
360 Keen Street, Burkesville, KY 42717-7915 | |
(270) 864-2889 | |
(270) 864-2229 |
Full Name | Dr Stefanie Dolen |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 10 Years |
Location | 360 Keen Street, Burkesville, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003229220 | NPI | - | NPPES |
7100480790 | Medicaid | KY | |
14102106 | Other | CAQH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 04010 (Kentucky) | Secondary |
207R00000X | Internal Medicine | 04010 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Columbia, KY | Home health agency |
Cumberland County Hospital | Burkesville, KY | Hospital |
Russell County Hospital | Russell springs, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cumberland Family Medical Center, Inc. | 6305947789 | 94 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.
New research will enhance corona safety during cruises and help cruise lines again attract passengers onboard.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.
The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).
› Verified 6 days ago
Entity Name | Lake Cumberland Regional Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861078685 PECOS PAC ID: 7214909456 Enrollment ID: O20040809001229 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.
New research will enhance corona safety during cruises and help cruise lines again attract passengers onboard.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.
The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).
› Verified 6 days ago
Entity Name | Cumberland Family Medical Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306873500 PECOS PAC ID: 6305947789 Enrollment ID: O20120221000433 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.
New research will enhance corona safety during cruises and help cruise lines again attract passengers onboard.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.
The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stefanie Dolen, DO Po Box 1080, Burkesville, KY 42717-1080 Ph: (270) 858-6655 | Dr Stefanie Dolen, DO 360 Keen Street, Burkesville, KY 42717-7915 Ph: (270) 864-2889 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.
New research will enhance corona safety during cruises and help cruise lines again attract passengers onboard.
Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.
Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.
The Obamacare Web site doesn't work. Hundreds of thousands of insured Americans are seeing their plans summarily terminated. Millions more face the same prospect next year. Confronted with a crisis of governance, how does President Obama respond? He campaigns (Charles Krauthammer, 11/7).
› Verified 6 days ago
Dr. Karan J Soni, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 299 Glasgow, Burkesville, KY 42717 Phone: 270-864-2511 |